By Tom Winnifrith | Sunday 22 July 2018
Disclosure: Financial Investigative Media Limited, which is not owned by Tom Winnifrith but by a trust for his dependants, owns shares in companies mentioned in this article. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Ok, I am back from a 22-24 mile walk which I shall write up tomorrow but if you could smell my feet? I know many of you hav e donated to Woodlarks ahead of next Saturday's 32 mile stroll by myself, Brokerman Dan and Lucian Miers and we have now raised £14,267.88 but to those who have not donated, PLEASE DO SO NOW HERE. In today's podcast I discuss the CBI talking Brexit shite again - it does NOT speak for British industry. I remind you we have no house view, ref Sosandar (SOS). I raise two questions arising out of a Saturday lunch Joshua and I had with Highland Natural Resources (HNR), notably who will back my new goat lending business. And I look at an ex Mellon stock, Okyo Pharma (OKYO), its valuation is a 100% rum and coke and I explain why.